UBS Group upgraded shares of Rentokil Initial (LON:RTO – Free Report) from a neutral rating to a buy rating in a research note issued to investors on Thursday, Marketbeat Ratings reports. They currently have GBX 540 price objective on the stock, up from their previous price objective of GBX 430.
Other equities research analysts also recently issued reports about the company. Stifel Nicolaus restated a “hold” rating and set a GBX 390 price objective on shares of Rentokil Initial in a research report on Thursday, March 5th. Jefferies Financial Group lifted their target price on Rentokil Initial from GBX 540 to GBX 550 and gave the stock a “buy” rating in a report on Tuesday. Five research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Rentokil Initial has an average rating of “Moderate Buy” and an average price target of GBX 450.71.
View Our Latest Stock Report on RTO
Rentokil Initial Price Performance
Rentokil Initial Company Profile
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers. The company provides hygiene services, including the provision and maintenance of products, such as soap and hand sanitizer dispensers, hand dryers, air care and purification, cubicle and surface sanitizers, feminine hygiene units, toilet paper dispensers, and floor protection mats.
Further Reading
- Five stocks we like better than Rentokil Initial
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
- Silver paying 20% dividend. Plus 68% share gains
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.
